- Tytuł:
- Efficacy and safety of vorolanib plus everolimus in metastatic renal cell carcinoma: A three-arm, randomised, double-blind, multicentre phase III study (CONCEPT)
- Autorzy:
- Źródło:
- In European Journal of Cancer January 2023 178:205-215
Czasopismo naukowe